Skip to main content

Deals

Olympus Partners-backed PAI Pharma strikes deal for Nexus Pharmaceuticals

Monday, November 16, 2026 · first reported by PEI Private Equity

Olympus Partners-backed PAI Pharma has struck a deal for Nexus Pharmaceuticals.

Also named
PAI Pharma, Nexus Pharmaceuticals
Asset class
Private equity

The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.

See an error?

Got news? Send it to us →